Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man
- PMID: 3025419
Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man
Abstract
Beta adrenergic relaxation of vascular smooth muscle, mediated by cyclic AMP, is blunted with age in a variety of experimental animals. The applicability of these observations to man is uncertain. The dorsal hand vein technique provides an excellent method to examine the direct effects of aging on vascular responsiveness. Thirty-nine healthy male volunteers over the age range of 19 to 79 were studied. No differences in vascular responsiveness to phenylephrine, an alpha adrenergic agonist, were found for either the ED50 (dose producing 50% vasoconstriction) or Emax (maximum vasoconstriction attained). In marked contrast, vascular relaxation induced by isoproterenol, a beta adrenergic agonist, was significantly different in both the ED50 (dose producing 50% of maximum relaxation from a preconstricted state) and Emax (maximum relaxation attained). ED50 +/- S.E.M. for the youngest and oldest deciles were 8.9 +/- 2.3 and 60 +/- 17.0 ng/min, respectively (P less than .05); Emax +/- S.E.M. were 96.7 +/- 3.3 and 37.7 +/- 8.7%, respectively (P less than .001). Nitroglycerin, a smooth muscle relaxant whose effects are not mediated through the cyclic AMP system, was also used to examine the specificity of this blunted response to isoproterenol. Almost complete relaxation was achieved with the infusion of nitroglycerin in the older group. These results suggest that aging is associated with a specific decrease in beta adrenoreceptor-mediated vascular relaxation.
Similar articles
-
Age-related decrease in beta adrenergic receptor-mediated vascular smooth muscle relaxation.J Pharmacol Exp Ther. 1986 Nov;239(2):411-5. J Pharmacol Exp Ther. 1986. PMID: 2430092
-
Pulmonary vascular smooth muscle relaxation by cGMP- versus cAMP-mediated mechanisms.J Surg Res. 1994 Aug;57(2):259-63. doi: 10.1006/jsre.1994.1141. J Surg Res. 1994. PMID: 7913147
-
Desensitization of beta-adrenergic receptor-mediated vascular smooth muscle relaxation.Mol Pharmacol. 1985 Feb;27(2):210-7. Mol Pharmacol. 1985. PMID: 2578603
-
Role of cyclic AMP-dependent protein kinase in the diminished beta adrenergic responsiveness of vascular smooth muscle with increasing age.J Pharmacol Exp Ther. 1989 Jun;249(3):812-9. J Pharmacol Exp Ther. 1989. PMID: 2543812
-
Age-related changes in vascular adrenergic signaling: clinical and mechanistic implications.Ageing Res Rev. 2003 Apr;2(2):169-90. doi: 10.1016/s1568-1637(02)00063-6. Ageing Res Rev. 2003. PMID: 12605959 Review.
Cited by
-
Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet.J Clin Invest. 1990 Mar;85(3):647-52. doi: 10.1172/JCI114487. J Clin Invest. 1990. PMID: 2155921 Free PMC article.
-
Age-related changes in adenosine and beta-adrenoceptor responsiveness of vascular smooth muscle in man.Br J Clin Pharmacol. 1992 Jan;33(1):83-7. doi: 10.1111/j.1365-2125.1992.tb04004.x. Br J Clin Pharmacol. 1992. PMID: 1311596 Free PMC article.
-
Pharmacokinetic optimisation of drug therapy in elderly patients.Drugs Aging. 1995 Jul;7(1):10-8. doi: 10.2165/00002512-199507010-00002. Drugs Aging. 1995. PMID: 7579777 Review.
-
Comparison of the effects of nadolol and bisoprolol on noradrenaline-evoked venoconstriction in man in vivo.Br J Clin Pharmacol. 1998 Mar;45(3):271-6. doi: 10.1046/j.1365-2125.1998.00683.x. Br J Clin Pharmacol. 1998. PMID: 9517371 Free PMC article. Clinical Trial.
-
Anaesthesia and postoperative analgesia in older patients with chronic obstructive pulmonary disease: special considerations.Drugs Aging. 2003;20(5):347-60. doi: 10.2165/00002512-200320050-00004. Drugs Aging. 2003. PMID: 12696995 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical